PRODUCT DETAIL

Imatinib Glenmark 100 mg filmom obalené tablety

Code

3991A

MA number

44/0027/13-S

Product Form:

tbl flm 90x100 mg (blis.PVC/PE/PVDC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EA	BCR-ABL tyrosine kinase inhibitors
L01EA01	Imatinib

Shelf life:

Container:

blister PVC/PE/PVDC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	30.01.2013
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
SPC:	SPC_Imatinib Glenmark 100 mg filmom obalené tablety_09.2023.pdf
PIL:	PIL_Imatinib Glenmark 100 mg filmom obalené tablety_09.2023.pdf
Safety feature	Yes
Data update:	17.01.2022